Company
Headquarters: Rosario, Argentina
Employees: 400
CEO: Dr. Federico Trucco Ph.D.
AR$505.4 Million
ARS as of Jan. 1, 2025
US$490,170
Company | Market Cap (USD) |
---|---|
Corteva, Inc. | $44.12 B |
Nutrien Ltd. | $22.05 B |
CF Industries Holdings, Inc. | $16.57 B |
SABIC Agri-Nutrients Company | $14.22 B |
The Mosaic Company | $9.15 B |
Company | Market Cap (USD) |
---|---|
Linde | $209.90 B |
BHP | $151.21 B |
Rio Tinto | $102.04 B |
Air Liquide SA | $97.26 B |
The Sherwin-Williams Company | $90.95 B |
Bioceres Crop Solutions Corp., together with its subsidiaries, provides crop productivity solutions. It operates through three segments: Seed and Integrated Products, Crop Protection, and Crop Nutrition. The Seed and Integrated Products segment develops and commercializes seed technology, biotechnological events, germplasm, and seed treatments. The Crop Protection segment develops, produces, and markets Rizoderma, adjuvants, therapies, herbicides, insecticides, fungicides, and baits. The Crop Nutrition segment develops, produces, commercializes, and sells inoculants, bio-inductors, and biological and microgranulated fertilizers. The company also offers HB4, a drought tolerant seed technology program. It operates in Argentina, Uruguay, France, South Africa, and internationally. The company was founded in 2001 and is headquartered in Rosario, Argentina. Bioceres Crop Solutions Corp. is a subsidiary of Bioceres LLC.
Top 1-year algo backtest: +327.04%
$10,000 in March 2024 would now be $42,704 by following this algorithm daily at market close.
Use AI to boost your investing & swing trading, now!
Try Disfold DeepFinance FREE
Last Financial Reports Date | Sept. 30, 2024 |
Revenue TTM | AR$446.31 B |
EBITDA | AR$57.7 M |
Gross Profit TTM | AR$182.4 M |
Profit Margin | 0.55% |
Operating Margin | 4.32% |
Quarterly Revenue Growth | -20.30% |
Bioceres Crop Solutions Corp. has the following listings and related stock indices.
Stock: BCBA: BIOX wb_incandescent
Stock: NYSE: BIOX wb_incandescent
Stock: FSX: 0G4 wb_incandescent
Stock: NASDAQ: BIOX wb_incandescent